Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator–Ineligible Patients | Zendy

Letícia C. Rebello | Zendy; Diogo C Haussen | Zendy; Jonathan A Grossberg | Zendy; Samir Belagaje | Zendy; Andrey Lima | Zendy; Aaron Anderson | Zendy; Michael Frankel | Zendy; Raul G. Nogueira | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator–Ineligible Patients

Author(s) -

Letícia C. Rebello,

Diogo C Haussen,

Jonathan A Grossberg,

Samir Belagaje,

Andrey Lima,

Aaron Anderson,

Michael Frankel,

Raul G. Nogueira

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.012586

Subject(s) - medicine , modified rankin scale , tissue plasminogen activator , stroke (engine) , surgery , univariate analysis , fibrinolytic agent , intracerebral hemorrhage , retrospective cohort study , glasgow coma scale , ischemic stroke , ischemia , multivariate analysis , mechanical engineering , engineering

Intravenous tissue-type plasminogen activator (tPA) treatment in acute stroke has many exclusion criteria. We aimed to assess the safety and efficacy of endovascular therapy (ET) in intravenous (IV) tPA-ineligible patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research